Clinical Trial Update: A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 study evaluating oral desmopressin in previously untreated children aged 5 to 15 years with primary nocturnal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturnal Enuresis

Drugs mentioned

• Desmopressin (Desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturnal Enuresis | Phase 4 | Status: COMPLETED